Early-Stage Funding: Fewer Start-Ups Raising Cash In '05
This article was originally published in Start Up
Executive Summary
Fundraising among biotech firms classified as start-ups by Windhover's Strategic Intelligence Systems was way down in the first quarter of 2005 compared to the same quarter in 2004, perhaps reflecting the growing difficulties of early-stage fundraising as venture capitalists focus on companies with clinical-stage projects.
You may also be interested in...
Start-Up Device Funding: A Slow Start to 2005
The total funds raised by medical device companies classified as start-ups by SIS in the first quarter of 2005 was off 2004's pace, although the average size of each round increased.
Start-Up Device Funding: A Slow Start to 2005
The total funds raised by medical device companies classified as start-ups by SIS in the first quarter of 2005 was off 2004's pace, although the average size of each round increased.
The A-List: 2004's Trend-Shaping Series A Financings
Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. Here we point out eleven 2004 Series A financings that identify and illustrate what's hot.